An evaluation of cyclosporine ophthalmic solution 0.09% vs cyclosporine ophthalmic emulsion 0.05% on tear volume in an NOD mice model

被引：0
|
作者：
Luchs, Jodi [1 ]
Burade, Vinod [2 ]
Zalawadia, Rishit [2 ]
Patel, Alpesh [2 ]
Ogundele, Abayomi B. [3 ]
机构：
[1] Florida Vis Inst, W Palm Beach, FL USA
[2] Sun Pharmaceut Ind Ltd, Mumbai, Maharashtra, India
[3] Sun Pharmaceut Ind Ltd, Princeton, NJ USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2020年 / 61卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
105
引用
收藏
页数：3
相关论文
共 35 条
  • [1] Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
    Burade, Vinod
    Zalawadia, Rishit
    Patel, Alpesh
    Ogundele, Abayomi
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 2747 - 2755
  • [2] CYCLOSPORINE OPHTHALMIC SOLUTION 0.09% IMPROVES THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE IN PATIENTS WHOSE DISEASE IS INADEQUATELY CONTROLLED ON CYCLOSPORINE OPHTHALMIC EMULSION 0.05%
    Johnston, J.
    Adler, R.
    Hessen, M.
    Nichols, K.
    Pflugfelder, S.
    Truett, K.
    Urbieta, M.
    Reynolds, R.
    VALUE IN HEALTH, 2024, 27 (06) : S32 - S32
  • [3] Use of cyclosporine A 0.05% ophthalmic emulsion for a distinctive intrapalpebral phenotype of anterior scleritis
    Grullon, Jason Rafael
    Mueller, Christian
    Iacob, Codrin E.
    Swan, Robert
    BMJ CASE REPORTS, 2025, 18 (02)
  • [4] Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes
    Willen, Christi M.
    McGwin, Gerald
    Liu, Bin
    Owsley, Cynthia
    Rosenstiel, Carol
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2008, 34 (01): : 43 - 45
  • [5] Effects of postoperative cyclosporine ophthalmic emulsion 0.05% (Restasis) following glaucoma surgery
    Fakhraie, Ghasem
    Lopes, Joao F.
    Spaeth, George L.
    Almodin, Juliana
    Ichhpujani, Parul
    Moster, Marlene R.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (09): : 842 - 848
  • [6] Effect of cyclosporine ophthalmic solution 0.09% on conjunctival staining in patients with keratoconjunctivitis sicca
    Ogundele, Abayomi B.
    Karpecki, Paul
    Devries, Douglas
    Darby, Charles
    Luchs, Jodi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [7] A RETROSPECTIVE ANALYSIS OF REAL-WORLD TREATMENT PATTERNS IN PATIENTS OVER AGE 64 WITH DRY EYE DISEASE RECEIVING OTX-101 OPHTHALMIC SOLUTION 0.09%, CYCLOSPORINE OPHTHALMIC EMULSION 0.05%, OR LIFITEGRAST OPHTHALMIC SOLUTION 5%
    Karpecki, P.
    Barghout, V
    Schenkel, B.
    Huynh, L.
    Khanal, A.
    Mitchell, B.
    Yenikomshian, M.
    Zanardo, E.
    Matossian, C.
    VALUE IN HEALTH, 2023, 26 (06) : S337 - S337
  • [8] BUDGET IMPACT OF USING CYCLOSPORINE OPHTHALMIC SOLUTION 0.09% FOR THE TREATMENT OF DRY EYE DISEASE
    Bloudek, L.
    Zhao, Y.
    Ogundele, A.
    Brown, D.
    Carlton, R.
    VALUE IN HEALTH, 2019, 22 : S166 - S167
  • [9] Cyclosporine 0.05% ophthalmic emulsion for the treatment of radiation-associated dry eye in children
    Hoehn, Mary Ellen
    Kelly, Steven R.
    Wilson, Matthew W.
    Walton, R. Christopher
    PEDIATRIC BLOOD & CANCER, 2013, 60 (07) : E35 - E37
  • [10] Real-world utilization patterns of cyclosporine ophthalmic emulsion 0.05% within managed care
    Chiang, TH
    Walt, JG
    McMahon, JP
    Mansfield, JE
    VALUE IN HEALTH, 2006, 9 (03) : A142 - A142
1234